Scotia Capital’s Teladoc Health TDOC Stock Holding History

Scotia Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-17,742	Closed	-$330K	–	831
2023 Q3	$330K	Buy	17,742 +9,803	+123%	+$229K	﹤0.01%	627
2023 Q2	$201K	Buy	+7,939	New	+$200K	﹤0.01%	731
2021 Q4	–	Sell	-13,889	Closed	-$1.76M	–	912
2021 Q3	$1.76M	Sell	13,889 -385	-3%	-$56.1K	0.01%	418
2021 Q2	$2.37M	Buy	14,274 +1,868	+15%	+$303K	0.02%	366
2021 Q1	$2.25M	Buy	12,406 +774	+7%	+$180K	0.02%	344
2020 Q4	$2.33M	Buy	11,632 +2,464	+27%	+$501K	0.02%	311
2020 Q3	$2.01M	Buy	+9,168	New	+$1.94M	0.02%	293

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Scotia Capital's TDOC Position: Q4 2023 in Review

Scotia Capital sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 17,742 shares — an estimated $330K sold.

Scotia Capital first reported a position in TDOC in Q3 2020 and held it in 7 quarters. The position peaked at $2.37M in Q2 2021. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

Scotia Capital reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
Scotia Capital sold 17,742 Teladoc Health shares in Q4 2023, an estimated $330K.
Scotia Capital first reported a position in Teladoc Health in Q3 2020 and held it in 7 quarters.
Scotia Capital's Teladoc Health position peaked at $2.37M in Q2 2021.
435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Scotia Capital's 13F filing for Q4 2023, filed 12 Feb 2024.